Literature DB >> 14678761

Acetylcholinesterase induces the expression of the beta-amyloid precursor protein in glia and activates glial cells in culture.

Rommy von Bernhardi1, Gigliola Ramírez, Giancarlo V De Ferrari, Nibaldo C Inestrosa.   

Abstract

Acetylcholinesterase (AChE) activities in CNS physiopathology are increasingly diverse and range from neuritogenesis, through synaptogenesis, to enhancement of amyloid fiber assembly. In Alzheimer's disease, senile plaques and neurodegeneration specially affect regions enriched for cholinergic synapses. In this study we show an effect of AChE that could contribute to the increased deposition of Abeta in certain regions. Affinity-purified AChE induced the expression of amyloid-beta-precursor protein (beta-APP) in glial cells in a concentration-dependent manner up to 5 nM. In glia, AChE also increased inducible nitric oxide synthase (iNOS) assessed by immunocytochemistry and decreased reductive metabolism as evidence of cell activation. AChE could increase the expression of beta-APP in astrocytes and microglia as result of the activation of glial cells. As a whole, we found that AChE has additional effects that could result in an increased synthesis of Abeta, both by increasing beta-APP expression of astrocytes and by further activating glial cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14678761     DOI: 10.1016/j.nbd.2003.08.014

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  7 in total

1.  Effect of long-term exposure to aluminum on the acetylcholinesterase activity in the central nervous system and erythrocytes.

Authors:  R R Kaizer; M C Corrêa; L R S Gris; C S da Rosa; D Bohrer; V M Morsch; Maria Rosa Chitolina Schetinger
Journal:  Neurochem Res       Date:  2008-05-10       Impact factor: 3.996

Review 2.  Cellular stress reactions as putative cholinergic links in Alzheimer's disease.

Authors:  Debra Toiber; Hermona Soreq
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

Review 3.  Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil.

Authors:  Moussa B H Youdim; Tamar Amit; Orit Bar-Am; Orly Weinreb; Mara Yogev-Falach
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 4.  Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.

Authors:  Chaitanya R Joshi; Vinod Labhasetwar; Anuja Ghorpade
Journal:  J Neuroimmune Pharmacol       Date:  2017-02-03       Impact factor: 4.147

5.  Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.

Authors:  Agneta Nordberg; Taher Darreh-Shori; Elaine Peskind; Hilkka Soininen; Malahat Mousavi; Gina Eagle; Roger Lane
Journal:  Curr Alzheimer Res       Date:  2009-02       Impact factor: 3.498

6.  Acetylcholinesterase loosens the brain's cholinergic anti-inflammatory response and promotes epileptogenesis.

Authors:  Yehudit Gnatek; Gabriel Zimmerman; Yael Goll; Naim Najami; Hermona Soreq; Alon Friedman
Journal:  Front Mol Neurosci       Date:  2012-05-18       Impact factor: 5.639

7.  Assessments of Ceanothanes Triterpenes as Cholinesterase Inhibitors: An Investigation of Potential Agents with Novel Inspiration for Drug Treatment of Neurodegenerative Diseases.

Authors:  Evelyn Muñoz-Nuñez; Soledad Quiroz-Carreño; Edgar Pastene-Navarrete; David S Seigler; Carlos Céspedes-Acuña; Ignacio Martínez Valenzuela; Martina Oppliger Muñoz; Alexis Salas-Burgos; Julio Alarcón-Enos
Journal:  Metabolites       Date:  2022-07-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.